AI in mental health.
India is confronting a mental health crisis of unprecedented scale. Estimates from the Global Burden of Disease study indicate that nearly 197 million people roughly one in seven Indians live with some form of mental disorder, with depression and anxiety alone affecting more than 90 million. Yet the majority never receive adequate care. Treatment gaps frequently exceed 70-80 per cent, and in many rural areas approach 90 per cent.
A primary driver of this gap is the acute shortage of trained professionals. India has approximately 0.75 psychiatrists per 100,000 population, well below the WHO recommendation of at least three (and even the more modest global average of 1.3-1.7). With only about 9,000 practising psychiatrists nationwide, the country would need more than 36,000 simply to meet basic benchmarks a shortfall that current training pipelines will take decades to close. Clinical psychologists and other specialists are even scarcer, with just over 4,300 registered clinical psychologists according to the Rehabilitation Council of India.
Against this backdrop, artificial intelligence is emerging not as a substitute for human expertise but as a practical force multiplier. Tools that analyse voice patterns during therapy sessions, for example, can detect subtle shifts in anxiety, confidence, emotional valence and social engagement that may be difficult for a busy clinician to track consistently in real time. When combined with continuous biometric data from wearables heart-rate variability, sleep disruption or physiological markers of stress these insights can be compiled into concise, objective reports. The result is more precise monitoring of progress, earlier detection of relapse risk, and reduced time spent on documentation.
As Sumukha U has observed: "We are entering an era where AI doesn't just listen to what we say it hears who we are. The human voice is no longer just a medium for language; it is a live, biometric broadcast of our internal biology." This framing captures why voice analysis is particularly powerful in mental health: the voice carries involuntary signals of physiology and emotional state that can complement clinical observation.
One concrete illustration is GIA Helps, the AI-powered platform developed by Bengaluru-based Velectron Labs. Launched in 2024, the system pairs a smart ring that monitors vital signs and anxiety markers with real-time voice analysis during therapy. The AI evaluates vocal cues for indicators of confidence, anxiety and engagement, then synthesises the data alongside physiological readings into actionable reports for therapists. Clinicians can begin a session already informed about recent episodes, track longitudinal patterns more objectively, and free cognitive bandwidth for the relational aspects of care. Early feedback from the company suggests that such automation can enable therapists to manage a larger caseload without sacrificing quality roughly ten patients in the time previously required for six.
This approach aligns with a clear principle articulated by Abhijit Nair, CEO of Velectron Labs: "In healthcare, artificial intelligence is meant to help humans increase their effectiveness, not replace them. Healthcare remains an extremely human endeavour.
The distinction is essential. Mental health care depends on empathy, clinical judgement, cultural sensitivity and the therapeutic alliance qualities that cannot be fully automated. AI's most responsible contribution is therefore to handle the measurable, repetitive and data-intensive elements of practice: continuous monitoring, pattern recognition across sessions, and streamlined reporting. By doing so, it can stretch the limited supply of trained professionals further, improve consistency of observation, and give clinicians more time for the work only humans can do.
Kabir Kashyap, Chief Marketing Officer at the company, notes that the broader market for such solutions "is still evolving at an exponential rate," reflecting both the urgency of unmet need and the rapid maturation of enabling technologies.
India's mental health infrastructure will not be rebuilt overnight. Expanding the training pipeline, reducing stigma and increasing public funding remain indispensable. In the interim, carefully designed AI systems that remain firmly in the service of human clinicians offer a practical means of increasing both reach and quality. When technology is positioned as an amplifier rather than a replacement, it can help close the care gap while preserving the fundamentally human character of healing.
The global market for AI-enabled mental health solutions is expanding rapidly. Estimates place the AI in mental health market at roughly USD 1.5-1.7 billion in 2025, with projections ranging from USD 9-11 billion by 2033-2034 at compound annual growth rates of 23-25 per cent. Broader digital mental health platforms including apps, teletherapy and wearables - are valued between USD 12-16 billion in 2026 and are forecast to reach USD 50-58 billion by the mid-2030s.
Voice and vocal biomarker technologies form a fast-growing segment within this landscape. The global vocal biomarker market, valued at approximately USD 0.8-1.6 billion in 2025, is projected to reach USD 2-4.7 billion by 2033-2035, growing at CAGRs of 10-17 per cent. Mental health applications (depression, anxiety and related conditions) already account for a substantial share often 30-40 per cent driven by demand for non-invasive, continuous monitoring that can extend clinician capacity. North America currently leads adoption, while Asia-Pacific is expected to record the fastest growth as systems seek scalable ways to address severe professional shortages.
